You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 20, 2025

Details for Patent: 11,090,312


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,090,312 protect, and when does it expire?

Patent 11,090,312 protects NATESTO and is included in one NDA.

This patent has sixteen patent family members in fourteen countries.

Summary for Patent: 11,090,312
Title:Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
Abstract:The present invention relates to methods of treating hypogonadism in a male subject through administering intranasally to the male subject an intranasal testosterone bio-adhesive gel formulation to deliver a therapeutically effective amount of testosterone. In particular, the testosterone therapy of the invention remains effective if an allergic rhinitis event occurs in the male during the treatment or when the male subject uses a topical nasal vasoconstrictor or a topical intranasal decongestant during the hypogonadism treatment. Further, the present invention relates to a method of preventing the occurrence of an allergic rhinitis event in a male, who is undergoing a hypogonadism treatment with an intranasal testosterone bio-adhesive gel. In certain embodiments, the intranasal testosterone bio-adhesive gel formulation according to the invention comprises 4.0% and 4.5% testosterone.
Inventor(s):Natalia Tkachenko
Assignee:Acerus Biopharma Inc
Application Number:US16/905,610
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,090,312: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent holders, and competitors alike. This article will delve into the specifics of United States Patent 11,090,312, exploring its claims, the patent landscape, and the implications of its issuance.

Understanding Patent Claims

Before diving into the specifics of US Patent 11,090,312, it is essential to understand what patent claims are and their significance.

  • Patent Claims: These are the legal definitions of the invention, outlining what the inventor considers to be the novel and non-obvious aspects of their invention. Claims are the heart of a patent, defining the scope of protection granted by the patent office[3].

The Patent in Question: US 11,090,312

To analyze the scope and claims of US Patent 11,090,312, we need to look at the patent document itself. Here is a general outline of what such an analysis would entail:

Title and Abstract

The title and abstract provide a brief overview of the invention. This section sets the stage for understanding the broader context of the patent.

Background of the Invention

This section explains the existing technology and the problems it addresses. It helps in understanding the need for the invention and its potential impact.

Summary of the Invention

Here, the inventors summarize the key aspects of their invention, including its novel features and how it improves upon existing technology.

Detailed Description of the Invention

This is the most detailed part of the patent, where the inventors describe their invention in full, often including diagrams, flowcharts, and detailed explanations.

Claims Analysis

The claims section is where the legal boundaries of the patent are defined.

Independent Claims

These claims stand alone and define the broadest scope of the invention. They are typically the most important claims as they set the outer limits of what is protected.

Dependent Claims

These claims build upon the independent claims, adding additional limitations or features. They are narrower in scope but can provide additional protection by covering specific embodiments of the invention.

Patent Scope and Coverage

The scope of a patent is determined by its claims. Here’s how to assess the scope of US Patent 11,090,312:

Claim Construction

Claim construction involves interpreting the language of the claims to determine their meaning and scope. This is often a critical step in patent litigation to determine infringement or validity[2].

Prior Art and Novelty

The patent must be novel and non-obvious over the prior art. The prior art search, often conducted using systems like the Automated Biotechnology Sequence Search (ABSS) system at the USPTO, helps in determining whether the invention is truly novel[1].

Patent Landscape

Understanding the patent landscape involves looking at related patents and the overall technological field.

Related Patents

Identifying other patents in the same technological field can help in understanding the competitive landscape and potential infringement issues. Datasets like the Patent Claims Research Dataset provided by the USPTO can be invaluable in this analysis[3].

Industry Trends

Analyzing industry trends and recent patent filings can provide insights into the direction of innovation in the field and potential future challenges or opportunities.

Economic and Strategic Implications

The value of a patent can be significant, both economically and strategically.

Monetary Value

The monetary value of a patent can vary widely, from tens of thousands to millions of dollars. Recent sales data show that patents can be highly valuable, especially in technology-intensive fields. For example, the Google-Motorola deal involved 24,500 patents and applications valued at over $12 billion[4].

Strategic Value

Patents can also have strategic value, providing a competitive edge and protecting market share. They can be used to block competitors, negotiate licensing agreements, or even as a bargaining chip in mergers and acquisitions.

Legal Considerations

Patents are subject to various legal considerations, including validity, infringement, and double patenting issues.

Validity

The validity of a patent can be challenged on grounds such as obviousness, lack of novelty, or inadequate disclosure. Recent cases like Allergan USA, Inc. v. MSN Laboratories Private Ltd. highlight the complexities involved in determining patent validity[2].

Infringement

Patent infringement occurs when someone makes, uses, sells, or imports a patented invention without permission. Determining infringement involves comparing the accused product or process against the claims of the patent.

Double Patenting

Double patenting, as seen in the Allergan case, is a doctrine that prevents an inventor from obtaining multiple patents for the same invention. This can be a critical issue in patent strategy and litigation[2].

Key Takeaways

  • Claims Are Key: The claims section of a patent defines its legal boundaries and is crucial for understanding the scope of protection.
  • Prior Art: Ensuring novelty and non-obviousness over prior art is essential for patent validity.
  • Economic and Strategic Value: Patents can have significant economic and strategic value, influencing business decisions and market dynamics.
  • Legal Considerations: Patents are subject to various legal challenges, including validity, infringement, and double patenting issues.

FAQs

Q: What is the primary purpose of patent claims? A: The primary purpose of patent claims is to legally define the invention and outline what the inventor considers to be the novel and non-obvious aspects of their invention.

Q: How do you determine the scope of a patent? A: The scope of a patent is determined by its claims, which are interpreted through claim construction to understand their meaning and scope.

Q: What is double patenting in patent law? A: Double patenting is a doctrine that prevents an inventor from obtaining multiple patents for the same invention, ensuring that an inventor can only obtain a single patent for an invention.

Q: How valuable can patents be? A: Patents can be highly valuable, both economically and strategically. They can be sold for millions of dollars and provide a competitive edge in the market.

Q: What datasets can be used to analyze the patent landscape? A: Datasets like the Patent Claims Research Dataset provided by the USPTO can be used to analyze the patent landscape and understand trends in patent filings and claims.

Sources

  1. U.S. Department of Commerce U.S. Patent and Trademark Office, "Privacy Threshold Analysis (PTA) for PSS-SS System," 2021.
  2. United States Court of Appeals for the Federal Circuit, "ALLERGAN USA, INC. v. MSN LABORATORIES PRIVATE LTD.," August 13, 2024.
  3. USPTO, "Patent Claims Research Dataset," August 28, 2017.
  4. Perpetual Motion Patents, "The Value of a Patent," 2021.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,090,312

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX Yes Yes 11,090,312 ⤷  Try for Free NASAL ADMINISTRATION OF A TESTOSTERONE GEL TO A PATIENT TO TREAT THE PATIENT FOR A CONDITION ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.